Respiratory Endotherapy Devices Market to Grow with a CAGR of 5.33% through 2028

Increasing prevalence of respiratory disorders are expected to drive the Global Respiratory Endotherapy Devices Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Respiratory Endotherapy Devices  Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Respiratory Endotherapy Devices Market stood at USD 1.45 Billion in 2022 and is anticipated to grow with a CAGR of 5.33% through 2028. Technology and improvements in artificial intelligence have dramatically changed the healthcare sector. Various market players are investing and innovating in the advancement of respiratory devices. For instance, in November 2022, Xplore Health Technologies launched a first-of-its-kind respiratory muscle training (RMT) device called Airofit Pro. The product comes from a collaboration with Airofit, Denmark. It was one of the first data-driven smart respiratory training systems and is priced at USD 422.74 (Rs 34,990). Airofit Pro personalizes the breathing training experience for users and makes their respiratory muscles stronger, faster, and more efficient. Therefore, with such technological advancements in respiratory devices, the market is expected to grow over the forecast period. Hence, as a result of the above-mentioned factors, such as the increasing prevalence of respiratory disorders and technological advancements and increasing applications in a homecare setting, the respiratory device market is anticipated to grow over the forecast period. However, the high cost of devices is likely to restrain the market's growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Respiratory Endotherapy Devices Market”

The Global Respiratory Endotherapy Devices Market is segmented into Medication Type, Drug Type, Route Of Administration, Distribution Channel, and company.

Based on the Devices, the Diagnostic Devices segment is anticipated to witness substantial market growth throughout the forecast period. The growth trajectory of the Global Respiratory Endotherapy Devices Market is significantly propelled by the pivotal role of diagnostic devices in shaping respiratory healthcare. Diagnostic devices play a crucial role in the early and accurate identification of respiratory disorders, setting the stage for the adoption of respiratory endotherapy solutions. Advanced diagnostic tools, such as high-resolution imaging systems and innovative sensors, provide healthcare practitioners with a comprehensive understanding of respiratory conditions, enabling targeted and personalized treatment approaches. These diagnostic devices not only contribute to early disease detection but also facilitate precise pre-procedural planning for respiratory endotherapy interventions. The seamless integration of diagnostic technologies into respiratory endotherapy devices enhances procedural accuracy, aiding healthcare professionals in navigating the respiratory system with precision during interventions.  As the demand for timely and accurate respiratory diagnostics rises globally, the symbiotic relationship between diagnostic devices and respiratory endotherapy solutions becomes increasingly evident.

Based on the End User segment, the Peripheral Vascular Intervention segment has been the dominant force in the market. Hospital Pharmacies are poised to play a pivotal role in propelling the growth of the Global Respiratory Endotherapy Devices Market. As primary points of dispensing medications within healthcare institutions, hospital pharmacies are critical stakeholders in the effective management and treatment of infectious diseases, including those caused by Pseudomonas Aeruginosa. The demand for specialized and advanced infection treatments is significantly high within hospital settings, where patients with severe infections often receive medical care. Hospital pharmacies are crucial in ensuring the availability and timely dispensing of cutting-edge Respiratory Endotherapy Devices, contributing directly to patient care and recovery. Furthermore, hospital pharmacies serve as hubs for healthcare professionals seeking the latest and most effective medications. As pharmaceutical companies introduce novel therapies and targeted treatments for Pseudomonas Aeruginosa infections, hospital pharmacies become key distribution channels, driving market growth through the dissemination of innovative drugs.

Major companies operating in Global Respiratory Endotherapy Devices Market are:

• Fujifilm Holdings Corporation.
• Medtronic plc.
• Johnson & Johnson.
• Smith & Nephew Plc.
• Stryker corporation.
• Olympus corporation.
• Hoya corporation.
• Steris Healthcare.
• Conmed corporation.
• Boston Scientific corporation.

Download Free Sample Report

Customers can also request 10% free customization on this report

“The Global Respiratory Endotherapy Devices Market is experiencing robust growth, driven by several key factors that underscore its significance in the healthcare industry. Firstly, the rising prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, is a primary driver. As these conditions become more prevalent globally, the demand for advanced and minimally invasive respiratory endotherapy devices is escalating. Technological advancements in endoscopic procedures and devices are playing a pivotal role in the market's growth. Innovations in bronchoscopy and other endotherapy techniques are enhancing diagnostic capabilities and treatment outcomes. The development of sophisticated devices with improved imaging capabilities and maneuverability is fostering greater adoption among healthcare professionals. An aging population contributes to the market's expansion, as the elderly are more prone to respiratory ailments. The growing awareness among both patients and healthcare providers about the benefits of endotherapy devices, such as reduced recovery time and minimal invasiveness, is also fueling market growth.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Respiratory Endotherapy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Devices {By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others), By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)}, By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others), By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Region, By Competition”, has evaluated the future growth potential of Global Respiratory Endotherapy Devices  Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Respiratory Endotherapy Devices Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]